Noile-Immune Biotech Inc., The Current Fiscal Year's Undisclosed Net Income to Narrow

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Nov 14, 2024 3:30 pm JST Earnings

4893 Noile-Immune Biotech Inc. 【J-GAAP】

Earnings Report

Noile-Immune Biotech Inc. <4893> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending December 2024 (January to September) was a reduced loss of 787 million yen (compared to a loss of 850 million yen in the same period last year).

In addition, the full-year forecast, which was not disclosed, indicated that net loss further decrease to loss of 994 million yen (compared to a loss of 1.13 billion yen in the previous period).

Based on the third-quarter cumulative performance announced by the company and the full-year plan, our calculation indicates that the net loss for the October to December period (4Q) is expected to further decrease to loss of 207 million yen (compared to a loss of 280 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the net loss expanded to a loss of 104 million yen (compared to a loss of 17 million yen in the same period last year). The operating profit/loss margin drastically worsened from -4.6% in the same period last year to -7033.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2023	314	-495	-848	-850	-20.8	ー	Nov 13, 2023	J-GAAP
Jan - Sep, 2024	5	-892	-785	-787	-18.2	ー	Nov 14, 2024	J-GAAP
YoY	-98.4%	-80.2%	+7.4%	+7.4%	+12.6%

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2024 Prev	ー	ー	ー	ー	－	0	Feb 13, 2024	J-GAAP
Jul - Dec, 2024 New	5	-418	-309	-311	-7.2	0	Nov 14, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2024 Prev	ー	ー	ー	ー	－	0	Feb 13, 2024	J-GAAP
Dec, 2024 New	7	-1,099	-991	-994	-23.0	0	Nov 14, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2023	305	-294	-295	-297	-7.2	0	Feb 13, 2024	J-GAAP
Jul - Dec, 2024 Guidance	5	-418	-309	-311	-7.2	0	Nov 14, 2024	J-GAAP
YoY	-98.4%	-42.2%	-4.7%	-4.7%	-0.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	316	-775	-1,127	-1,130	-27.3	0	Feb 13, 2024	J-GAAP
Dec, 2024 Guidance	7	-1,099	-991	-994	-23.0	0	Nov 14, 2024	J-GAAP
YoY	-97.8%	-41.8%	+12.1%	+12.0%	+15.7%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	303	-14	-16	-17	-0.4	-4.6	Nov 13, 2023	J-GAAP
Oct - Dec, 2023	2	-280	-279	-280	-6.8	-14,000.0	Feb 13, 2024	J-GAAP
Jan - Mar, 2024	2	-339	-339	-340	-7.9	-16,950.0	May 14, 2024	J-GAAP
Apr - Jun, 2024	0	-342	-343	-343	-7.9	-Inf	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	3	-211	-103	-104	-2.4	-7,033.3	Nov 14, 2024	J-GAAP
YoY	-99.0%	-1,407.1%	-543.8%	-511.8%	-471.4%